NCT06393153

Brief Summary

This study aims to develop and validate a Random Survival Forest (RSF) model for predicting long-term survival in elderly patients following curative resection for gastric cancer. The study is a retrospective multi-center analysis involving patients aged 75 and above who underwent gastric resection from January 2009 to December 2018 at nine top-tier hospitals in China. An online prognostic tool is introduced to assist clinicians in predicting patient prognosis and customizing treatment and follow-up strategies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,202

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 26, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 1, 2024

Completed
Last Updated

May 1, 2024

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

April 26, 2024

Last Update Submit

April 30, 2024

Conditions

Keywords

Stomach NeoplasmsPrognosisElderlyPrediction Model

Outcome Measures

Primary Outcomes (2)

  • 5-Year Overall Survival

    The proportion of patients who are alive at five years after treatment for elderly gastric cancer patients.

    5 years or 60 months.

  • 5-Year Disease-Free Survival

    The proportion of patients who have survived without any signs or symptoms of gastric cancer for five years after the initial treatment.

    5 years or 60 months.

Secondary Outcomes (4)

  • 3-Year Overall Survival

    3 years or 36 months.

  • 1-Year Overall Survival

    1 years or 12 months.

  • 3-Year Disease-Free Survival

    3 years or 36 months.

  • 1-Year Disease-Free Survival

    1 years or 12 months.

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population comprises elderly patients, aged 75 and above, diagnosed with gastric cancer and who underwent curative gastrectomy within a ten-year period from January 2009 to December 2018. The participants were selected from nine major tertiary care centers across China, ensuring a comprehensive representation of the demographic. The selection criteria were strictly adhered to, ensuring a uniform and high-quality dataset for subsequent analysis in developing a robust prognostic model. The study's focus on the elderly demographic addresses a significant gap in prognostic tools for this age group, which often presents with distinct clinical and therapeutic challenges.

You may qualify if:

  • Patients aged 75 years or older.
  • Histologically confirmed diagnosis of gastric cancer.
  • Patients who have undergone curative gastrectomy.

You may not qualify if:

  • Patients with non-primary gastric malignancies.
  • Pathological confirmation of metastatic disease (M1).
  • Incomplete follow-up data or loss to follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastric Surgery, Fujian Medical University Union Hospital

Fuzhou, Fujian, China

Location

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Officials

  • Chang-Ming Huang, M.D

    Fujian Medical University Union Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 26, 2024

First Posted

May 1, 2024

Study Start

January 1, 2024

Primary Completion

April 1, 2024

Study Completion

April 20, 2024

Last Updated

May 1, 2024

Record last verified: 2024-04

Locations